{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:47:44Z","timestamp":1793400464001,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81625007"],"award-info":[{"award-number":["81625007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471296"],"award-info":[{"award-number":["81471296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00401-017-1721-y","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T12:13:46Z","timestamp":1493986426000},"page":"207-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP\/PS1 mouse model"],"prefix":"10.1007","volume":"134","author":[{"given":"Wang-Sheng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Le","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ni","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-An","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-6112","authenticated-orcid":false,"given":"Yan-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"1721_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","volume":"88","author":"N Bien-Ly","year":"2015","unstructured":"Bien-Ly N, Boswell CA, Jeet S, Beach TG, Hoyte K, Luk W et al (2015) Lack of widespread BBB disruption in Alzheimer\u2019s disease models: focus on therapeutic antibodies. Neuron 88:289\u2013297. doi: 10.1016\/j.neuron.2015.09.036","journal-title":"Neuron"},{"key":"1721_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1161591","volume":"321","author":"DL Brody","year":"2008","unstructured":"Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N et al (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321:1221\u20131224. doi: 10.1126\/science.1161591","journal-title":"Science"},{"key":"1721_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12640-015-9552-x","volume":"28","author":"XL Bu","year":"2015","unstructured":"Bu XL, Cao GQ, Shen LL, Xiang Y, Jiao SS, Liu YH et al (2015) Serum amyloid-beta levels are increased in patients with chronic obstructive pulmonary disease. Neurotox Res 28:346\u2013351. doi: 10.1007\/s12640-015-9552-x","journal-title":"Neurotox Res"},{"key":"1721_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/ene.12477","volume":"22","author":"XL Bu","year":"2015","unstructured":"Bu XL, Yao XQ, Jiao SS, Zeng F, Liu YH, Xiang Y et al (2015) A study on the association between infectious burden and Alzheimer\u2019s disease. Eur J Neurol 22:1519\u20131525. doi: 10.1111\/ene.12477","journal-title":"Eur J Neurol"},{"key":"1721_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/nn.4163","volume":"18","author":"MA Busche","year":"2015","unstructured":"Busche MA, Grienberger C, Keskin AD, Song B, Neumann U, Staufenbiel M et al (2015) Decreased amyloid-beta and increased neuronal hyperactivity by immunotherapy in Alzheimer\u2019s models. Nat Neurosci 18:1725\u20131727. doi: 10.1038\/nn.4163","journal-title":"Nat Neurosci"},{"key":"1721_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/ars.2011.3895","volume":"15","author":"A Carrano","year":"2011","unstructured":"Carrano A, Hoozemans JJ, van der Vies SM, Rozemuller AJ, van Horssen J, de Vries HE (2011) Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 15:1167\u20131178. doi: 10.1089\/ars.2011.3895","journal-title":"Antioxid Redox Signal"},{"key":"1721_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s12264-014-1479-3","volume":"30","author":"GS Chai","year":"2014","unstructured":"Chai GS, Duan DX, Ma RH, Shen JY, Li HL, Ma ZW et al (2014) Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid beta-peptide in rats. Neurosci Bull 30:923\u2013935. doi: 10.1007\/s12264-014-1479-3","journal-title":"Neurosci Bull"},{"key":"1721_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.vph.2016.11.008","volume":"89","author":"A Chakraborty","year":"2017","unstructured":"Chakraborty A, de Wit NM, van der Flier WM, de Vries HE (2017) The blood brain barrier in Alzheimer\u2019s disease. Vascul Pharmacol 89:12\u201318. doi: 10.1016\/j.vph.2016.11.008","journal-title":"Vascul Pharmacol"},{"key":"1721_CR9","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","volume":"23","author":"JR Cirrito","year":"2003","unstructured":"Cirrito JR, May PC, O\u2019Dell MA, Taylor JW, Parsadanian M, Cramer JW et al (2003) In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23:8844\u20138853","journal-title":"J Neurosci"},{"key":"1721_CR10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33:1500\u20131513. doi: 10.1038\/jcbfm.2013.135","journal-title":"J Cereb Blood Flow Metab"},{"key":"1721_CR11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","volume":"122","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease and Down\u2019s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122:1131\u20131135","journal-title":"Biochem Biophys Res Commun"},{"key":"1721_CR12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"1721_CR13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(01)00102-3","volume":"36","author":"SM Gloor","year":"2001","unstructured":"Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K (2001) Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 36:258\u2013264","journal-title":"Brain Res Brain Res Rev"},{"key":"1721_CR14","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jnr.21944","volume":"87","author":"H Guan","year":"2009","unstructured":"Guan H, Liu Y, Daily A, Police S, Kim MH, Oddo S et al (2009) Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer\u2019s disease. J Neurosci Res 87:1462\u20131473. doi: 10.1002\/jnr.21944","journal-title":"J Neurosci Res"},{"key":"1721_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/brain\/awt308","volume":"137","author":"SJ Henderson","year":"2013","unstructured":"Henderson SJ, Andersson C, Narwal R, Janson J, Goldschmidt TJ, Appelkvist P et al (2013) Sustained peripheral depletion of amyloid-beta with a novel form of neprilysin does not affect central levels of amyloid-beta. Brain 137:553\u201364. doi: 10.1093\/brain\/awt308","journal-title":"Brain"},{"key":"1721_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ et al (2016) Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540:230\u2013235. doi: 10.1038\/nature20587","journal-title":"Nature"},{"key":"1721_CR17","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.1074\/jbc.M710509200","volume":"283","author":"K Iijima-Ando","year":"2008","unstructured":"Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, Chiang HC et al (2008) Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila. J Biol Chem 283:19066\u201319076. doi: 10.1074\/jbc.M710509200","journal-title":"J Biol Chem"},{"key":"1721_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-0270(85)90107-4","volume":"15","author":"I Jacobson","year":"1985","unstructured":"Jacobson I, Sandberg M, Hamberger A (1985) Mass transfer in brain dialysis devices\u2013a new method for the estimation of extracellular amino acids concentration. J Neurosci Methods 15:263\u2013268","journal-title":"J Neurosci Methods"},{"key":"1721_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12640-015-9589-x","volume":"29","author":"SS Jiao","year":"2016","unstructured":"Jiao SS, Bu XL, Liu YH, Zhu C, Wang QH, Shen LL et al (2016) Sex Dimorphism profile of Alzheimer\u2019s disease-type pathologies in an APP\/PS1 mouse model. Neurotox Res 29:256\u2013266. doi: 10.1007\/s12640-015-9589-x","journal-title":"Neurotox Res"},{"key":"1721_CR20","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1422998112","volume":"112","author":"SS Jiao","year":"2015","unstructured":"Jiao SS, Yao XQ, Liu YH, Wang QH, Zeng F, Lu JJ et al (2015) Edaravone alleviates Alzheimer\u2019s disease-type pathologies and cognitive deficits. Proc Natl Acad Sci USA 112:5225\u20135230. doi: 10.1073\/pnas.1422998112","journal-title":"Proc Natl Acad Sci USA"},{"key":"1721_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/341226a0","volume":"341","author":"CL Joachim","year":"1989","unstructured":"Joachim CL, Mori H, Selkoe DJ (1989) Amyloid beta-protein deposition in tissues other than brain in Alzheimer\u2019s disease. Nature 341:226\u2013230. doi: 10.1038\/341226a0","journal-title":"Nature"},{"key":"1721_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00702-015-1431-3","volume":"122","author":"N Kitaguchi","year":"2015","unstructured":"Kitaguchi N, Hasegawa M, Ito S, Kawaguchi K, Hiki Y, Nakai S et al (2015) A prospective study on blood Abeta levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer\u2019s disease. J Neural Transm (Vienna, Austria: 1996) 122:1593\u20131607. doi: 10.1007\/s00702-015-1431-3","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"key":"1721_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrneurol.2012.118","volume":"8","author":"YH Liu","year":"2012","unstructured":"Liu YH, Giunta B, Zhou HD, Tan J, Wang YJ (2012) Immunotherapy for Alzheimer disease: the challenge of adverse effects. Nat Rev Neurol 8:465\u2013469. doi: 10.1038\/nrneurol.2012.118","journal-title":"Nat Rev Neurol"},{"key":"1721_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-014-8694-9","volume":"51","author":"YH Liu","year":"2015","unstructured":"Liu YH, Wang YR, Xiang Y, Zhou HD, Giunta B, Manucat-Tan NB et al (2015) Clearance of amyloid-beta in Alzheimer\u2019s disease: shifting the action site from center to periphery. Mol Neurobiol 51:1\u20137. doi: 10.1007\/s12035-014-8694-9","journal-title":"Mol Neurobiol"},{"key":"1721_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12035-014-8854-y","volume":"52","author":"YH Liu","year":"2015","unstructured":"Liu YH, Xiang Y, Wang YR, Jiao SS, Wang QH, Bu XL et al (2015) Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance. Mol Neurobiol 52:115\u2013119. doi: 10.1007\/s12035-014-8854-y","journal-title":"Mol Neurobiol"},{"key":"1721_CR26","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1172\/JCI79742","volume":"125","author":"SL Macauley","year":"2015","unstructured":"Macauley SL, Stanley M, Caesar EE, Yamada SA, Raichle ME, Perez R et al (2015) Hyperglycemia modulates extracellular amyloid-beta concentrations and neuronal activity in vivo. J Clin Invest 125:2463\u20132467. doi: 10.1172\/JCI79742","journal-title":"J Clin Invest"},{"key":"1721_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol 9:702\u2013716. doi: 10.1016\/S1474-4422(10)70119-8","journal-title":"Lancet Neurol"},{"key":"1721_CR28","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245\u20134249","journal-title":"Proc Natl Acad Sci USA"},{"key":"1721_CR29","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330:1774. doi: 10.1126\/science.1197623","journal-title":"Science"},{"key":"1721_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JA Nicoll","year":"2003","unstructured":"Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448\u2013452. doi: 10.1038\/nm840","journal-title":"Nat Med"},{"key":"1721_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15:673\u2013684. doi: 10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"key":"1721_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3747\/pdi.2011.00271","volume":"33","author":"C Pipili","year":"2013","unstructured":"Pipili C, Polydorou A, Pantelias K, Korfiatis P, Nikolakopoulos F, Grapsa E (2013) Improvement of hepatic encephalopathy by application of peritoneal dialysis in a patient with non-end-stage renal disease. Perit Dial Int 33:213\u2013216. doi: 10.3747\/pdi.2011.00271","journal-title":"Perit Dial Int"},{"key":"1721_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ana.24270","volume":"76","author":"KF Roberts","year":"2014","unstructured":"Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE et al (2014) Amyloid-beta efflux from the central nervous system into the plasma. Ann Neurol 76:837\u2013844. doi: 10.1002\/ana.24270","journal-title":"Ann Neurol"},{"key":"1721_CR34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3233\/JAD-151139","volume":"51","author":"K Sakai","year":"2016","unstructured":"Sakai K, Senda T, Hata R, Kuroda M, Hasegawa M, Kato M et al (2016) Patients that have undergone hemodialysis exhibit lower amyloid deposition in the brain: evidence supporting a therapeutic strategy for Alzheimer\u2019s disease by removal of blood amyloid. J Alzheimers Dis 51:997\u20131002. doi: 10.3233\/JAD-151139","journal-title":"J Alzheimers Dis"},{"key":"1721_CR35","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","volume":"73","author":"S Salloway","year":"2009","unstructured":"Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M et al (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73:2061\u20132070. doi: 10.1212\/WNL.0b013e3181c67808","journal-title":"Neurology"},{"key":"1721_CR36","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E et al (2012) Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA 109:3510\u20133515. doi: 10.1073\/pnas.1112209109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1721_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. doi: 10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"1721_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/089686080502500105","volume":"25","author":"NHL Siska Mortier","year":"2005","unstructured":"Siska Mortier NHL, De Vriese An S (2005) Animal models in peritoneal dialysis research: a need for consensus. Perit Dial Int 25:16\u201324","journal-title":"Perit Dial Int"},{"key":"1721_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3233\/jad-150662","volume":"50","author":"S Tholen","year":"2016","unstructured":"Tholen S, Schmaderer C, Chmielewski S, Forstl H, Heemann U, Baumann M et al (2016) Reduction of amyloid-beta plasma levels by hemodialysis: an anti-amyloid treatment strategy? J Alzheimers disease 50:791\u2013796. doi: 10.3233\/jad-150662","journal-title":"J Alzheimers disease"},{"key":"1721_CR40","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","volume":"68","author":"L Troncone","year":"2016","unstructured":"Troncone L, Luciani M, Coggins M, Wilker EH, Ho CY, Codispoti KE et al (2016) Abeta amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: mind the heart. J Am Coll Cardiol 68:2395\u20132407. doi: 10.1016\/j.jacc.2016.08.073","journal-title":"J Am Coll Cardiol"},{"key":"1721_CR41","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1523\/JNEUROSCI.3407-12.2013","volume":"33","author":"JR Walker","year":"2013","unstructured":"Walker JR, Pacoma R, Watson J, Ou W, Alves J, Mason DE et al (2013) Enhanced proteolytic clearance of plasma Abeta by peripherally administered neprilysin does not result in reduced levels of brain Abeta in mice. J Neurosci 33:2457\u20132464. doi: 10.1523\/JNEUROSCI.3407-12.2013","journal-title":"J Neurosci"},{"key":"1721_CR42","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s12035-016-9826-1","volume":"54","author":"YR Wang","year":"2016","unstructured":"Wang YR, Wang QH, Zhang T, Liu YH, Yao XQ, Zeng F et al (2016) Associations between hepatic functions and plasma amyloid-beta levels-implications for the capacity of liver in peripheral amyloid-beta clearance. Mol Neurobiol 54:2338\u20132344. doi: 10.1007\/s12035-016-9826-1","journal-title":"Mol Neurobiol"},{"key":"1721_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fnbeh.2014.00234","volume":"8","author":"X Wu","year":"2014","unstructured":"Wu X, Bai Y, Tan T, Li H, Xia S, Chang X et al (2014) Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats. Front Behav Neurosci 8:234. doi: 10.3389\/fnbeh.2014.00234","journal-title":"Front Behav Neurosci"},{"key":"1721_CR44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu XL, Liu YH, Zhu C, Shen LL, Jiao SS et al (2015) Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 130:487\u2013499. doi: 10.1007\/s00401-015-1477-1","journal-title":"Acta Neuropathol"},{"key":"1721_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12264-011-1015-7","volume":"27","author":"H Xiong","year":"2011","unstructured":"Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY et al (2011) Biochemical and behavioral characterization of the double transgenic mouse model (APPswe\/PS1dE9) of Alzheimer\u2019s disease. Neurosci Bull 27:221\u2013232. doi: 10.1007\/s12264-011-1015-7","journal-title":"Neurosci Bull"},{"key":"1721_CR46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/mp.2015.49","volume":"20","author":"XQ Yao","year":"2015","unstructured":"Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C et al (2015) p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer\u2019s disease. Mol Psychiatry 20:1301\u20131310. doi: 10.1038\/mp.2015.49","journal-title":"Mol Psychiatry"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1721-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T21:18:22Z","timestamp":1602019102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1721-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1721"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1721-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727594488.793534780","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}